Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population

Joon Ho Kwon, Moon Jae Chung, Jeong Youp Park, Hee Seung Lee, Ho Kyoung Hwang, Chang Moo Kang, Woo Jung Lee, Mi Suk Park, Namo Kim, Seungmin Bang, Man Deuk Kim

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Background: Locally advanced pancreatic cancer (LAPC) is one of the most aggressive malignancies. Irreversible electroporation (IRE) is a novel technique that uses a non-thermal ablation to avoid vessel or duct injury. Purpose: To investigate the safety and efficacy of IRE for the management of LAPC in a Korean population. Material and Methods: Twelve patients (median age 64 years; age range 46–73 years) treated between December 2015 and March 2017 underwent intraoperative IRE for LAPC. Technical success and clinical outcomes, including complications, serum pancreatic enzyme levels, overall survival (OS), and progression-free survival (PFS), were evaluated. Results: Tumors were located in the pancreas head in 7 (58.3%) patients and in the body/tail in 5 (41.7%) patients. The median tumor diameter in the longest axis was 3.1 cm. Vascular invasion was observed in all patients and bowel abutment in 3 (25%) patients. Technical success was achieved in all patients. The median serum levels of amylase and lipase were 55 U/L and 31 U/L, respectively, at baseline, increased to 141.5 U/L (P = 0.008) and 53 U/L (P = 0.505), respectively, one day after IRE, and normalized after one week. The rate of 30-day mortality of unknown relation was 8.3% (one individual experienced massive hematemesis 12 days after IRE). The median OS from diagnosis and IRE was 24.5 months and 13.5 months, respectively. The median PFS from diagnosis and IRE was 19.2 months and 8.6 months, respectively. Conclusion: For patients with LAPC, IRE appears to be a promising treatment modality with an acceptable safety profile.

Original languageEnglish
Pages (from-to)164-171
Number of pages8
JournalActa Radiologica
Issue number2
Publication statusPublished - 2021 Feb

Bibliographical note

Funding Information:
The author(s) received the following financial support for the research, authorship, and/or publication of this article: This research was supported by the “Conditional Approval System of Health Technology” funded by the Ministry of Health and Welfare (Grant No. CAS-2015-01-02). The funder has no role in the present study.

Publisher Copyright:
© The Foundation Acta Radiologica 2020.

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population'. Together they form a unique fingerprint.

Cite this